NorthStar
NorthStar’s Radiopharmaceutical CDMO/CMO unit offers customized services and expertise to accelerate biopharmaceutical companies’ development and commercialization programs. The NorthStar CDMO is the first and only U.S. facility providing commercial-scale, multi-radioisotope production and radiopharmaceutical development on-site. With a 52,000 sq. ft. footprint, it sets new industry standards, serving the growing therapeutic and diagnostic radiopharmaceuticals market. Our facility effectively supports the entire product lifecycle, with cGMP and radiation safety programs to ensure high-quality and safe practices.
